Page last updated: 2024-09-04

atrasentan and Injury, Myocardial Reperfusion

atrasentan has been researched along with Injury, Myocardial Reperfusion in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukumoto, T; Matsumura, Y; Ohkita, M; Tawa, M1
Ayajiki, K; Fukumoto, T; Geddawy, A; Imamura, T; Matsumura, Y; Ohkita, M; Okamura, T; Tawa, M; Yamashita, N1
Fukumoto, T; Kitada, K; Matsumura, Y; Ohkita, M; Okamura, T; Tawa, M; Yamashita, N1
Fujita, M; Gariepy, CE; Kanazawa, M; Matsumoto, N; Matsumura, Y; Takaoka, M; Yamamoto, S; Yanagisawa, M1
Fujita, M; Kanazawa, M; Matsumoto, N; Matsumura, Y; Takaoka, M; Yamamoto, S1
Brunner, F; Kirchengast, M; Pang, X; Stessel, H; Wölkart, G1

Other Studies

6 other study(ies) available for atrasentan and Injury, Myocardial Reperfusion

ArticleYear
Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    European journal of pharmacology, 2008, Sep-04, Volume: 591, Issue:1-3

    Topics: Animals; Aspartic Acid Endopeptidases; Atrasentan; Endothelin-1; Endothelin-Converting Enzymes; Enzyme Inhibitors; Glycopeptides; Male; Metalloendopeptidases; Myocardial Ischemia; Myocardial Reperfusion Injury; Norepinephrine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Sulfonamides; Sulfonylurea Compounds

2008
Effects of exogenous big endothelin-1 on postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:2

    Topics: Animals; Aspartic Acid Endopeptidases; Atrasentan; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Male; Metalloendopeptidases; Myocardial Reperfusion Injury; Norepinephrine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Sulfonamides; Sulfonylurea Compounds; Ventricular Dysfunction, Left

2011
Different effects of AT1 receptor antagonist and ET(A) receptor antagonist on ischemia-induced norepinephrine release in rat hearts.
    Journal of cardiovascular pharmacology, 2012, Volume: 60, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Atrasentan; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Norepinephrine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors

2012
Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Circulation, 2005, Jan-25, Volume: 111, Issue:3

    Topics: Amiloride; Animals; Animals, Genetically Modified; Atrasentan; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Gene Deletion; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Norepinephrine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Regional Blood Flow; Ventricular Pressure

2005
Effects of ET(A) and ET(B) receptor blockade on post-ischemic cardiac dysfunction and norepinephrine overflow in isolated rat hearts.
    Journal of cardiovascular pharmacology, 2004, Volume: 44 Suppl 1

    Topics: Animals; Atrasentan; Cardiovascular Agents; Coronary Circulation; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; Norepinephrine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sympathetic Nervous System; Time Factors; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Pressure

2004
Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.
    British journal of pharmacology, 2007, Volume: 151, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Female; Fibrosis; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Oxidative Stress; Pyrrolidines; Ramipril; Rats; Rats, Sprague-Dawley; Streptozocin; Ventricular Function, Left; Ventricular Pressure

2007